MMPs in learning and memory and neuropsychiatric disorders

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works

Diagnostic and Statistical Manual of Mental Disorders(DSM)

Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,858 · see citing works

Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )

Segal, D. L. (2010) · Wiley eBooks · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,683 · see citing works

How Matrix Metalloproteinases Regulate Cell Behavior

Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959 · see citing works

Bipolar Disorder

Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515 · see citing works

A Systematic Review of the Prevalence of Schizophrenia

Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168 · see citing works

Regulation of Cell Survival by Secreted Proneurotrophins

Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670 · see citing works

Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

Strongin, A. Y., Collier, I. E., Bannikov, G. A., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,589 · see citing works

Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice

Liao, D., Hessler, N. A., & Malinow, R. (1995) · Nature · doi:10.1038/375400a0 · Cited by 1,365 · see citing works

The brain on drugs: from reward to addiction

Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306 · see citing works

Introduction to Behavioral Addictions

Grant, J. E., Potenza, M. N., Weinstein, A., & Gorelick, D. A. (2010) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2010.491884 · Cited by 1,242 · see citing works

Mossy fiber synaptic reorganization in the epileptic human temporal lobe

Sutula, T. P., Cascino, G. D., Cavazos, J. E., Parada, I., & Ramirez, L. F. (1989) · Annals of Neurology · doi:10.1002/ana.410260303 · Cited by 1,152 · see citing works

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., & Lipton, S. A. (2002) · Science · doi:10.1126/science.1073634 · Cited by 950 · see citing works

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

Pei, D., & Weiss, S. J. (1995) · Nature · doi:10.1038/375244a0 · Cited by 629 · see citing works

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.

Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619 · see citing works

Mechanisms of epileptogenesis and potential treatment targets

Pitkänen, A., & Łukasiuk, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70310-0 · Cited by 614 · see citing works

The dual role of the extracellular matrix in synaptic plasticity and homeostasis

Dityatev, A., Schachner, M., & Sonderegger, P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2898 · Cited by 559 · see citing works

Epidemiology of Posttraumatic Epilepsy: A Critical Review

Frey, L. C. (2003) · Epilepsia · doi:10.1046/j.1528-1157.44.s10.4.x · Cited by 515 · see citing works

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory

Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499 · see citing works

Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders

Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494 · see citing works

What is a mental/psychiatric disorder? From DSM-IV to DSM-V

Stein, D. J., Phillips, K. A., Bolton, D., Fulford, K. W. M., Sadler, J. Z., & Kendler, K. S. (2010) · Psychological Medicine · doi:10.1017/s0033291709992261 · Cited by 481 · see citing works

Dendritic Spines: The Locus of Structural and Functional Plasticity

Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465 · see citing works

Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model

Bilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W., & Ethell, I. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061796 · Cited by 465 · see citing works

η-Secretase processing of APP inhibits neuronal activity in the hippocampus

Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398 · cited 1× · see citing works

Matrix Metalloproteinase-9 Undergoes Expression and Activation during Dendritic Remodeling in Adult Hippocampus

Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. G., & Kaczmarek, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00920.2002 · Cited by 392 · see citing works

MMP ‐9 in translation: from molecule to brain physiology, pathology, and therapy

Vafadari, B., Salamian, A., & Kaczmarek, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 381 · see citing works

Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury

Wang, X., Jung, J., Asahi, M., Chwang, W. B., Russo, L. A., Moskowitz, M. A., Dixon, C. E., Fini, M. E., & Lo, E. H. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-07037.2000 · Cited by 371 · see citing works

Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S. L., McKeown, A., Brittain, C. F., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 347 · see citing works

Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade

Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344 · see citing works

New medications for drug addiction hiding in glutamatergic neuroplasticity

Kalivas, P. W., & Volkow, N. D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.46 · Cited by 342 · see citing works

Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately

Wang, X.-B., Bozdagi, O., Nikitczuk, J. S., Zhai, Z. W., Zhou, Q., & Huntley, G. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807248105 · Cited by 316 · see citing works

A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome

Leigh, M. J. S., Nguyen, D. V., Mu, Y., Winarni, T. I., Schneider, A., Chechi, T., Polussa, J., Doucet, P., Tassone, F., Rivera, S. M., et al. (2013) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318287cd17 · Cited by 298 · see citing works

First seizure definitions and worldwide incidence and mortality

Hauser, W. A., & Beghi, E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01443.x · Cited by 294 · see citing works

Cytokine functions of TIMP-1

Ries, C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1457-3 · Cited by 294 · see citing works

Important role of matrix metalloproteinase 9 in epileptogenesis

Wilczynski, G. M., Konopacki, F. A., Wilczek, E., Lasiecka, Z., Gorlewicz, A., Michaluk, P., Wawrzyniak, M., Malinowska, M., Okulski, P., Kolodziej, L. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708213 · Cited by 292 · see citing works

In Vivo Cocaine Experience Generates Silent Synapses

Huang, Y. H., Lin, Y., Mu, P., Lee, B. R., Brown, T. E., Wayman, G. A., Marie, H., Liu, W., Yan, Z., Sorg, B. A., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.007 · Cited by 290 · see citing works

Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2

Olson, M. W., Gervasi, D. C., Mobashery, S., & Fridman, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29975 · Cited by 288 · see citing works

Effects of extracellular matrix‐degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity

Meighan, S. E., Meighan, P. C., Choudhury, P., Davis, C. J., Olson, M. L., Zornes, P. A., Wright, J. W., & Harding, J. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03565.x · Cited by 285 · see citing works

Synaptic circuit remodelling by matrix metalloproteinases in health and disease

Huntley, G. W. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3320 · Cited by 282 · see citing works

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder

Yoshida, T., Ishikawa, M., Niitsu, T., Nakazato, M., Watanabe, H., Shiraishi, T., Shiina, A., Hashimoto, T., Kanahara, N., Hasegawa, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042676 · Cited by 278 · see citing works

Matrix Metalloproteinase-3: A Novel Signaling Proteinase from Apoptotic Neuronal Cells That Activates Microglia

Kim, Y.-S., Kim, S. S., Cho, J., Choi, D.-H., Hwang, O., Shin, D., Hong, S.-C., Beal, M., & Joh, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4346-04.2005 · Cited by 272 · see citing works

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke

Anthony, D. C., Ferguson, B., Matyzak, M. K., Miller, K., Esiri, M. M., & Perry, V. H. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01315.x · Cited by 268 · see citing works

Molecular signals of plasticity at the tetrapartite synapse

Dityatev, A., & Rusakov, D. A. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.12.006 · Cited by 267 · see citing works

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system

Cuzner, M. L., & Opdenakker, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00241-0 · Cited by 265 · see citing works

Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.

Pagenstecher, A., Stalder, A. K., Kincaid, C., Shapiro, S., & Campbell, I. L. (1998) · Europe PMC (PubMed Central) · Cited by 263 · see citing works

Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae

Leppert, D., Leib, S. L., Grygar, C., Miller, K., Schaad, U. B., & Holländer, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313922 · Cited by 261 · see citing works

Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain

Dzwonek, J., Rylski, M., & Kaczmarek, L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.070 · Cited by 256 · see citing works

Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?

Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3467-10.2010 · Cited by 237 · see citing works

Bipolar disorder

Anderson, I. M., Haddad, P. M., & Scott, J. L. (2012) · BMJ · doi:10.1136/bmj.e8508 · Cited by 237 · see citing works

Expression and Activation of Matrix Metalloproteinase-2 and -9 in Rat Brain after Transient Focal Cerebral Ischemia

Planas, A. M., Solé, S., & Justicia, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0435 · Cited by 231 · see citing works

Metformin ameliorates core deficits in a mouse model of fragile X syndrome

Gantois, I., Khoutorsky, A., Popić, J., Aguilar‐Valles, A., Freemantle, E., Cao, R., Sharma, V. K., Pooters, T., Nagpal, A., Skalecka, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4335 · Cited by 228 · see citing works

Transsynaptic Signaling by Activity-Dependent Cleavage of Neuroligin-1

Peixoto, R. T., Kunz, P. A., Kwon, H., Mabb, A. M., Sabatini, B. L., Philpot, B. D., & Ehlers, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.006 · Cited by 224 · see citing works

Aberrant learning and memory in addiction

Torregrossa, M. M., Corlett, P. R., & Taylor, J. R. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.014 · Cited by 223 · see citing works

Open-label add-on treatment trial of minocycline in fragile X syndrome.

Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I. M., & Ethell, D. W. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-91 · Cited by 223 · see citing works

A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.

Reinhard, S. M., Razak, K., & Ethell, I. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00280 · Cited by 219 · see citing works

Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology

Michaluk, P., Wawrzyniak, M., Alot, P., Szczot, M., Wyrembek, P., Mercik, K., Medvedev, N., Wilczek, E., De Roo, M., Zuschratter, W., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.090852 · Cited by 214 · see citing works

Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes

Muir, E. M., Adcock, K. H., Morgenstern, D. A., Clayton, R., von Stillfried, N., Rhodes, K., Ellis, C., Fawcett, J. W., & Rogers, J. H. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00132-8 · Cited by 206 · see citing works

Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling

Michaluk, P., Mikasová, L., Groc, L., Frischknecht, R., Choquet, D., & Kaczmarek, L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5346-08.2009 · Cited by 204 · see citing works

Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes

Gkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201 · see citing works

Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases

Ogata, Y., Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18506 · Cited by 200 · see citing works

Matrix Metalloproteinase-9 Contributes to Kindled Seizure Development in Pentylenetetrazole-Treated Mice by Converting Pro-BDNF to Mature BDNF in the Hippocampus

Mizoguchi, H., Nakade, J., Tachibana, M., Ibi, D., Someya, E., Koike, H., Kamei, H., Nabeshima, T., Itohara, S., Takuma, K., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3118-11.2011 · Cited by 199 · see citing works

Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis

Gorter, J. A., van Vliet, E. A., & Aronica, E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.047 · Cited by 194 · see citing works

Matrix metalloproteases and PAR1 activation

Austin, K. M., Covic, L., & Kuliopulos, A. (2012) · Blood · doi:10.1182/blood-2012-09-355958 · Cited by 192 · see citing works

β-Dystroglycan as a Target for MMP-9, in Response to Enhanced Neuronal Activity

Michaluk, P., Kolodziej, L. R., Mioduszewska, B., Wilczynski, G. M., Dzwonek, J., Jaworski, J., Górecki, D. C., Ottersen, O. P., & Kaczmarek, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700641200 · Cited by 189 · see citing works

Spatiotemporal Expression Patterns of Metalloproteinases and Their Inhibitors in the Postnatal Developing Rat Cerebellum

Vaillant, C., Didier‐Bazès, M., Hutter, A., Belin, M., & Thomasset, N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04994.1999 · Cited by 188 · see citing works

Activity-dependent exocytosis of lysosomes regulates the structural plasticity of dendritic spines

Padamsey, Z., McGuinness, L., Bardo, S. J., Reinhart, M., Tong, R., Hedegaard, A., Hart, M. L., & Emptage, N. J. (2017) · Neuron · doi:10.1016/j.neuron.2016.11.013 · Cited by 186 · see citing works

In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity

Bozdagi, O., Nagy, V., Kwei, K. T., & Huntley, G. W. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00202.2007 · Cited by 182 · see citing works

CD44: molecular interactions, signaling and functions in the nervous system

Dzwonek, J., & Wilczynski, G. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00175 · Cited by 180 · see citing works

Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate

Jourquin, J., Tremblay, E., Décanis, N., Charton, G., Hanessian, S., Chollet, A., Le Diguardher, T., Khrestchatisky, M., & Rivera, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02876.x · Cited by 178 · see citing works

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions

Cossins, J. A., Clements, J. M., Ford, J., Miller, K., Pigott, R., Vos, W., van der Valk, P., & Groot, C. J. A. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050754 · Cited by 176 · see citing works

Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage

Tian, L., Stefanidakis, M., Lin, N., Lint, P. V., Nyman-Huttunen, H., Libert, C., Itohara, S., Mishina, M., Rauvala, H., & Gahmberg, C. G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612097 · Cited by 173 · see citing works

The history of matrix metalloproteinases: milestones, myths, and misperceptions

Iyer, R. P., Patterson, N. L., Fields, G. B., & Lindsey, M. L. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00577.2012 · Cited by 171 · see citing works

The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders

Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00270 · Cited by 170 · see citing works

Remodeling of neuronal circuitries in human temporal lobe epilepsy: Increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex

Mikkonen, M., Soininen, H. S., Kälviäinen, R. K., Tapiola, T., Ylinen, A., Vapalahti, M. P., Paljärvi, L., & Pitkänen, A. (1998) · Annals of Neurology · doi:10.1002/ana.410440611 · Cited by 169 · see citing works

Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1

Zhang, B., HENNEY, A. M., Eriksson, P. O., Hamsten, A., Watkins, H. C., & Ye, S. (1999) · Human Genetics · doi:10.1007/s004390051124 · Cited by 169 · see citing works

Opposing mechanisms mediate morphine- and cocaine-induced generation of silent synapses

Graziane, N., Sun, S., Wright, W. J., Jang, D., Liu, Z., Huang, Y. H., Nestler, E. J., Wang, Y. T., Schlüter, O. M., & Dong, Y. (2016) · Nature Neuroscience · doi:10.1038/nn.4313 · Cited by 169 · see citing works

Shaping Synapses by the Neural Extracellular Matrix

Ferrer-Ferrer, M., & Dityatev, A. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00040 · Cited by 169 · see citing works

The Hemopexin Domain of Matrix Metalloproteinase-9 Activates Cell Signaling and Promotes Migration of Schwann Cells by Binding to Low-Density Lipoprotein Receptor-Related Protein

Mantuano, E., Inoue, G., Li, X., Takahashi, K., Gaultier, A., Gonias, S. L., & Campana, W. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3053-08.2008 · Cited by 167 · see citing works

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis

Kieseier, B. C. (1998) · Brain · doi:10.1093/brain/121.1.159 · Cited by 163 · see citing works

High MMP-9 activity levels in fragile X syndrome are lowered by minocycline

Dziembowska, M., Pretto, D. I., Janusz, A., Kaczmarek, L., Leigh, M. J., Gabriel, N., Durbin‐Johnson, B., Hagerman, R. J., & Tassone, F. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36023 · Cited by 161 · see citing works

Inhibition of MMP‐3 or ‐9 suppresses lipopolysaccharide‐induced expression of proinflammatory cytokines and iNOS in microglia

Woo, M., Park, J., Choi, I., Kim, W., & Kim, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05430.x · Cited by 160 · see citing works

Schizoaffective Disorder in the DSM-5

Malaspina, D., Owen, M. J., Heckers, S., Tandon, R., Bustillo, J., Schultz, S. K., Barch, D. M., Gäebel, W., Gur, R. E., Tsuang, M. T., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.026 · Cited by 160 · see citing works

Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model

Sidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155 · see citing works

Matrix metalloproteinases in the adult brain physiology: a link between c‐Fos, AP‐1 and remodeling of neuronal connections?

Kaczmarek, L., Dzwonek, J., & Szymczak, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf676 · Cited by 154 · see citing works

TIMP-1 Abolishes MMP-9-Dependent Long-lasting Long-term Potentiation in the Prefrontal Cortex

Okulski, P., Jay, T. M., Jaworski, J., Duniec, K., Dzwonek, J., Konopacki, F. A., Wilczynski, G. M., Sánchez‐Capelo, A., Mallet, J. J., & Kaczmarek, L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.012 · Cited by 154 · see citing works

ELEVATION OF MATRIX METALLOPROTEINASES 3 AND 9 IN CEREBROSPINAL FLUID AND BLOOD IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY

Grossetete, M., Phelps, J., Arko, L., Yonas, H., & Rosenberg, G. A. (2009) · Neurosurgery · doi:10.1227/01.neu.0000351768.11363.48 · Cited by 149 · see citing works

Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Is Differentially Induced in Neurons and Astrocytes after Seizures: Evidence for Developmental, Immediate Early Gene, and Lesion Response

Rivera, S., Tremblay, E. C., Timsit, S., Canals, O., Ben-Ari, Y., & Khrestchatisky, M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04223.1997 · Cited by 145 · see citing works

Microtubule-Dependent Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Exocytosis

Schnaeker, E., Ossig, R., Ludwig, T. E., Dreier, R., Oberleithner, H., Wilhelmi, M., & Schneider, S. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0324 · Cited by 142 · see citing works

The fragile X syndrome–autism comorbidity: what do we really know?

Abbeduto, L., McDuffie, A. S., & Thurman, A. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00355 · Cited by 140 · see citing works

Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations

van der Kooij, M. A., Fantin, M., Rejmak, E., Grosse, J., Zanoletti, O., Fournier, C., Ganguly, K., Kalita, K., Kaczmarek, L., & Sandi, C. (2014) · Nature Communications · doi:10.1038/ncomms5995 · Cited by 140 · see citing works

Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases

Smith, A. C. W., Kupchik, Y. M., Scofield, M. D., Gipson, C. D., Wiggins, A., Thomas, C. A., & Kalivas, P. W. (2014) · Nature Neuroscience · doi:10.1038/nn.3846 · Cited by 133 · see citing works

Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid‐induced epileptic seizures

Penkowa, M., Florit, S., Giralt, M., Quintana, A., Molinero, A., Carrasco, J., & Hidalgo, J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20387 · Cited by 132 · see citing works

Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome

Rotschafer, S. E., Trujillo, M. S., Dansie, L. E., Ethell, I. M., & Razak, K. A. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.041 · Cited by 130 · see citing works

Differential vesicular distribution and trafficking of MMP‐2, MMP‐9, and their inhibitors in astrocytes

Sbai, O., Ould‐Yahoui, A., Ferhat, L., Gueye, Y., Bernard, A., Charrat, E., Mehanna, A., Risso, J., Chauvin, J., Fenouillet, E., et al. (2009) · Glia · doi:10.1002/glia.20927 · Cited by 129 · see citing works

Activity-Dependent Local Translation of Matrix Metalloproteinase-9

Dziembowska, M., Miłek, J., Janusz, A., Rejmak, E., Romanowska, E., Górkiewicz, T., Tiron, A., Bramham, C. R., & Kaczmarek, L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6028-11.2012 · Cited by 127 · see citing works

Extracellular Matrix Plasticity and GABAergic Inhibition of Prefrontal Cortex Pyramidal Cells Facilitates Relapse to Heroin Seeking

van den Oever, M. C., Lubbers, B. R., Goriounova, N. A., Li, K. W., van der Schors, R. C., Loos, M., Riga, D., Wiskerke, J., Binnekade, R., Stegeman, M., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.90 · Cited by 126 · see citing works

Matrix metalloproteinase‐2 (MMP‐2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins

Ogier, C., Bernard, A., Chollet-Gravey, A.-M., Diguardher, T. L., Hanessian, S., Charton, G., Khrestchatisky, M., & Rivera, S. (2006) · Glia · doi:10.1002/glia.20349 · Cited by 124 · see citing works

Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Suppresses TKR-Growth Factor Signaling Independent of Metalloproteinase Inhibition

Hoegy, S. E., Oh, H.-R., Corcoran, M. L., & Stetler‐Stevenson, W. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008157200 · Cited by 123 · see citing works

Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference

Brown, T. E., Forquer, M. R., Cocking, D. L., Jansen, H. T., Harding, J. W., & Sorg, B. A. (2007) · Learning & Memory · doi:10.1101/lm.476207 · Cited by 121 · see citing works

Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling

Mash, D. C., ffrench‐Mullen, J. M. H., Adi, N., Qin, Y., Buck, A., & Pablo, J. P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001187 · Cited by 119 · see citing works

Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.

Lee, J., Lim, E., Kim, Y., Li, E., & Park, S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0040 · Cited by 119 · see citing works

Membrane Localization of Membrane Type 5 Matrix Metalloproteinase by AMPA Receptor Binding Protein and Cleavage of Cadherins

Monea, S., Jordan, B. A., Srivastava, S., deSouza, S., & Ziff, E. B. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3521-05.2006 · Cited by 117 · see citing works

Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome

Lovelace, J. W., Wen, T. H., Reinhard, S., Hsu, M. S., Sidhu, H., Ethell, I. M., Binder, D. K., & Razak, K. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.002 · Cited by 115 · see citing works

Influence of Therapeutic Hypothermia on Matrix Metalloproteinase Activity after Traumatic Brain Injury in Rats

Truettner, J. S., Alonso, O. F., & Dietrich, W. D. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600150 · Cited by 114 · see citing works

Matrix metalloproteinase‐3 in the central nervous system: a look on the bright side

Hove, I. V., Lemmens, K., de Velde, S. V., Verslegers, M., & Moons, L. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07900.x · Cited by 112 · see citing works

The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.

Janusz, A., Miłek, J., Perycz, M., Pacini, L., Bagni, C., Kaczmarek, L., & Dziembowska, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2207-13.2013 · Cited by 112 · see citing works

Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration

Zhang, J. W., Deb, S., & Gottschall, P. E. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00347.x · Cited by 109 · see citing works

Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain‐specific MMP highly expressed in cerebellum

Sekine‐Aizawa, Y., Hama, E., Watanabe, K., Tsubuki, S., Kanai‐Azuma, M., Kanai, Y., Arai, H., Aizawa, H., Iwata, N., & Saido, T. C. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01462.x · Cited by 108 · see citing works

Electrocortical changes associated with minocycline treatment in fragile X syndrome

Schneider, A., Leigh, M. J., Adams, P., Nanakul, R., Chechi, T., Olichney, J., Hagerman, R., & Hessl, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113494105 · Cited by 108 · see citing works

Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth.

Hayashita‐Kinoh, H., Kinoh, H., Okada, A., Komori, K., Itoh, Y., Chiba, T., Kajita, M., Yana, I., & Seiki, M. (2001) · PubMed · Cited by 106 · see citing works

Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development

Bronisz, E., & Kurkowska‐Jastrzębska, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/7369020 · Cited by 105 · see citing works

Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand.

Matsuno, H., Yudoh, K., Watanabe, Y., Nakazawa, F., Aono, H., & Kimura, T. (2001) · PubMed · Cited by 101 · see citing works

High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses

Gawlak, M., Górkiewicz, T., Gorlewicz, A., Konopacki, F. A., Kaczmarek, L., & Wilczynski, G. M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.045 · Cited by 101 · see citing works

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.

Yamamori, H., Hashimoto, R., Ishima, T., Kishi, F., Yasuda, Y., Ohi, K., Fujimoto, M., Umeda-Yano, S., Ito, A., Hashimoto, K., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.059 · Cited by 101 · see citing works

Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction

Michaluk, P., & Kaczmarek, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402141 · Cited by 100 · see citing works

Matrix metalloproteinase‐7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation

Bilousova, T. V., Rusakov, D. A., Ethell, D. W., & Ethell, I. M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03701.x · Cited by 98 · see citing works

Effects of matrix metalloproteinase inhibition on short‐ and long‐term plasticity of schaffer collateral/CA1 synapses

Meighan, P. C., Meighan, S. E., Davis, C. J., Wright, J. W., & Harding, J. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04682.x · Cited by 95 · see citing works

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease

Leake, A., Morris, C. M., & Whateley, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01418-x · Cited by 95 · see citing works

Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells

Sbai, O., Ferhat, L., Bernard, A., Gueye, Y., Ould‐Yahoui, A., Thiolloy, S., Charrat, E., Charton, G., Tremblay, E. C., Risso, J., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.08.004 · Cited by 93 · see citing works

Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression

RYBAKOWSKI, J. K., Remlinger-Molenda, A., Czech-Kucharska, A., Wójcicka, M., Michalak, M., & Losy, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.019 · Cited by 87 · see citing works

Reward Learning Requires Activity of Matrix Metalloproteinase-9 in the Central Amygdala

Knapska, E., Lioudyno, V. I., Kiryk, A., Mikosz, M., Górkiewicz, T., Michaluk, P., Gawlak, M., Chaturvedi, M., Mochol, G., Balcerzyk, M., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5239-12.2013 · Cited by 87 · see citing works

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders

Frye, M. A., Nassan, M. M., Jenkins, G. D., Kung, S., Veldić, M., Palmer, B. A., Feeder, S. E., Tye, S. J., Choi, D., & Biernacka, J. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.185 · Cited by 87 · see citing works

Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts

Södersten, K., Pålsson, E., Ishima, T., Funa, K., Landén, M., Hashimoto, K., & Ågren, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.009 · Cited by 85 · see citing works

Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats

Hayashi, T., Kaneko, Y., Yu, S., Bae, E. C., Stahl, C. E., Kawase, T., van Loveren, H., Sanberg, P. R., & Borlongan, C. V. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.040 · Cited by 85 · see citing works

Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases

Wright, J. W., Masino, A. J., Reichert, J. R., Turner, G. D., Meighan, S. E., Meighan, P. C., & Harding, J. W. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04036-2 · Cited by 85 · see citing works

Cytotoxicity by Matrix Metalloprotease-1 in Organotypic Spinal Cord and Dissociated Neuronal Cultures

Vos, C. M. P., Sjulson, L., Nath, A., McArthur, J. C., Pardo, C. A., Rothstein, J. D., & Conant, K. E. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7388 · Cited by 84 · see citing works

miR-132 Regulates Dendritic Spine Structure by Direct Targeting of Matrix Metalloproteinase 9 mRNA

Jasińska, M., Miłek, J., Cymerman, I. A., Łęski, S., Kaczmarek, L., & Dziembowska, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9383-z · Cited by 83 · see citing works

Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors

Szepesi, Z., Hosy, E., Ruszczycki, B., Bijata, M., Pyskaty, M., Bikbaev, A., Heine, M., Choquet, D., Kaczmarek, L., & Wlodarczyk, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098274 · Cited by 83 · see citing works

Matrix metalloproteinase‐3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury

Falo, M. C., Fillmore, H. L., Reeves, T. M., & Phillips, L. L. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20986 · Cited by 83 · see citing works

Disruption of the blood–brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels

Li, Y.-J., Wang, Z.-H., Zhang, B., Xiao, Z., Wang, M.-J., Shi, S., Bai, J., Lin, T., Guo, C., Zhang, S.-J., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-80 · Cited by 82 · see citing works

Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway

Kuzniewska, B., Rejmak, E., Malik, A. R., Jaworski, J., Kaczmarek, L., & Kalita, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00008-13 · Cited by 82 · see citing works

Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis

Kim, H. J., Fillmore, H. L., Reeves, T. M., & Phillips, L. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.014 · Cited by 81 · see citing works

Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology

Romi, F. R., Helgeland, G., & Gilhus, N. E. (2012) · European Neurology · doi:10.1159/000334862 · Cited by 78 · see citing works

Peptide Inhibition of Catalytic and Noncatalytic Activities of Matrix Metalloproteinase-9 Blocks Tumor Cell Migration and Invasion

Björklund, M., Heikkilä, P., & Koivunen, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401601200 · Cited by 78 · see citing works

Matrix Metalloproteinases and Their Inhibitors in the Developing Mouse Brain and Spinal Cord: A Reverse Transcription Quantitative Polymerase Chain Reaction Study

Ulrich, R., Gerhauser, I., Seeliger, F., Baumgärtner, W., & Alldinger, S. (2005) · Developmental Neuroscience · doi:10.1159/000088455 · Cited by 77 · see citing works

Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.

Rybakowski, J. K., Skibinska, M., Kapelski, P., Kaczmarek, L., & Hauser, J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.005 · Cited by 76 · see citing works

Reduction of methamphetamine‐induced sensitization and reward in matrix metalloproteinase‐2 and ‐9‐deficient mice

Mizoguchi, H., Yamada, K., Niwa, M., Mouri, A., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., & Nabeshima, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04288.x · Cited by 75 · see citing works

Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems

Hughes, P., Wells, G., Perry, V. H., Brown, M. C., & Miller, K. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00183-5 · Cited by 75 · see citing works

Neural ECM proteases in learning and synaptic plasticity

Tsilibary, E. C., Tzinia, A. K., Radenović, L., Stamenković, V., Lebitko, T., Mucha, M. W., Pawlak, R., Frischknecht, R., & Kaczmarek, L. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00006-2 · Cited by 74 · see citing works

Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures

Suenaga, N., Ichiyama, T., Kubota, M., Isumi, H., Tohyama, J., & Furukawa, S. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.09.011 · Cited by 73 · see citing works

Transient ECM protease activity promotes synaptic plasticity

Magnowska, M., Górkiewicz, T., Beroun, A., Wawrzyniak, M., Rutkowska-Włodarczyk, I., Kaczmarek, L., & Włodarczyk, J. (2016) · Scientific Reports · doi:10.1038/srep27757 · Cited by 73 · see citing works

Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer’s disease: evidence for a pro-amyloidogenic role of MT1-MMP

Py, N., Bonnet, A., Bernard, A., Marchalant, Y., Charrat, E., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00247 · Cited by 71 · see citing works

Elevation of MMP-9 Levels Promotes Epileptogenesis After Traumatic Brain Injury

Pijet, B., Stefaniuk, M., Kostrzewska-Księżyk, A., Tsilibary, P.-E., Tzinia, A. K., & Kaczmarek, L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1061-5 · Cited by 71 · see citing works

The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction

Smith, A. C. W., Scofield, M. D., & Kalivas, P. W. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.027 · Cited by 71 · see citing works

Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine‐induced behavioral sensitization and reward: implications for dopamine receptor down‐regulation and dopamine release

Mizoguchi, H., Yamada, K., Mouri, A., Niwa, M., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., & Nabeshima, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04623.x · Cited by 71 · see citing works

Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory

Wright, J. W., Brown, T. E., & Harding, J. W. (2007) · Neural Plasticity · doi:10.1155/2007/73813 · Cited by 71 · see citing works

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication

Kumarasinghe, N., Beveridge, N. J., Gardiner, E. J., Scott, R. J., Yasawardene, S. G., Perera, A., Mendis, J., Suriyakumara, K., Schall, U., & Tooney, P. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000035 · Cited by 70 · see citing works

Matrix Metalloproteinase-9 and Synaptic Plasticity in the Central Amygdala in Control of Alcohol-Seeking Behavior

Stefaniuk, M., Beroun, A., Lebitko, T., Markina, O. A., Łęski, S., Meyza, K. Z., Grzywacz, A., Samochowiec, J., Samochowiec, A., Radwańska, K., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.026 · Cited by 70 · see citing works

Adult ADHD vs. Bipolar Disorder in the DSM-5 Era: A Challenging Differentiation for Clinicians

BRUS, M. J., SOLANTO, M. V., & GOLDBERG, J. F. (2014) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000456591.20622.9e · Cited by 70 · see citing works

Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia

Chang, S.-H., Chiang, S., Chiu, C., Tsai, C.-C., Tsai, H.-H., Huang, C., Hsu, T., & Tzang, B. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.049 · Cited by 70 · see citing works

Autism phenotypes in ZnT3 null mice: Involvement of zinc dyshomeostasis, MMP-9 activation and BDNF upregulation

Yoo, M. H., Kim, T.-Y., Yoon, Y. H., & Koh, J. (2016) · Scientific Reports · doi:10.1038/srep28548 · Cited by 70 · see citing works

Amniotic Fluid MMP ‐9 and Neurotrophins in Autism Spectrum Disorders: An Exploratory Study

Abdallah, M. W., Pearce, B. D., Larsen, N., Greaves‐Lord, K., Nørgaard‐Pedersen, B., HOUGAARD, D. M., Mortensen, E. L., & Grove, J. (2012) · Autism Research · doi:10.1002/aur.1254 · Cited by 69 · see citing works

Caregiver burden in bipolar hypomania and mania: a systematic review.

Beentjes, T., Goossens, P., & Poslawsky, I. (2012) · Perspectives in psychiatric care · doi:10.1111/j.1744-6163.2012.00328.x · Cited by 69 · see citing works

Dynamic Changes of Proteases and Protease Inhibitors Revealed by Microarray Analysis in CA3 and Entorhinal Cortex during Epileptogenesis in the Rat

Gorter, J. A., van Vliet, E. A., Rauwerda, H., Breit, T. M., Stad, R. K., Schaik, L. V., Vreugdenhil, E., Redeker, S., Hendriksen, E., Aronica, E., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01290.x · Cited by 69 · see citing works

Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia

Konopka, A., Grajkowska, W., Ziemiańska, K., Roszkowski, M., Daszkiewicz, P., Rysz, A., Marchel, A., Koperski, Ł., Wilczynski, G. M., & Dzwonek, J. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.09.018 · Cited by 68 · see citing works

Matrix Metalloproteinases Regulate the Formation of Dendritic Spine Head Protrusions during Chemically Induced Long-Term Potentiation

Szepesi, Z., Bijata, M., Ruszczycki, B., Kaczmarek, L., & Włodarczyk, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063314 · Cited by 68 · see citing works

Latent MMP-9 is bound to TIMP-1 before secretion

Roderfeld, M., Graf, J., Giese, B., Salguero-Palacios, R., Tschuschner, A., Müller‐Newen, G., & Roeb, E. (2007) · Biological Chemistry · doi:10.1515/bc.2007.123 · Cited by 66 · see citing works

MT5-MMP, ADAM-10, and N-Cadherin Act in Concert To Facilitate Synapse Reorganization after Traumatic Brain Injury

Harrell, K. M., Reeves, T. M., & Phillips, L. L. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2383 · Cited by 65 · see citing works

Blocking human fear memory with the matrix metalloproteinase inhibitor doxycycline

Bach, D. R., Tzovara, A., & Vunder, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.65 · Cited by 64 · see citing works

The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus

Kim, G. W., Kim, H.-J., Cho, K.-J., Kim, H.-W., Cho, Y.-J., & Lee, B. I. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.008 · Cited by 63 · see citing works

Matrix Metalloproteinase-7 Regulates Cleavage of Pro-Nerve Growth Factor and Is Neuroprotective following Kainic Acid-Induced Seizures

Le, A. P., & Friedman, W. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4128-11.2012 · Cited by 63 · see citing works

Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: A possible role in homeostatic synaptic plasticity

Takács, E., Nyilas, R., Szepesi, Z., Baracskay, P., Karlsen, B., Røsvold, T., Bjørkum, A. A., Czurkó, A., Kovács, Z., Kékesi, A. K., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.003 · Cited by 63 · see citing works

MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITORS OF METALLOPROTEINASES 1 IN INFLUENZA-ASSOCIATED ENCEPHALOPATHY

Ichiyama, T., Morishima, T., Kajimoto, M., Matsushige, T., Matsubara, T., & Furukawa, S. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31803994a0 · Cited by 62 · see citing works

Increase in matrix metalloproteinase‐9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference

Brown, T. E., Forquer, M. R., Harding, J. W., Wright, J. W., & Sorg, B. A. (2008) · Synapse · doi:10.1002/syn.20562 · Cited by 61 · see citing works

Abnormal intrinsic dynamics of dendritic spines in a fragile X syndrome mouse model in vivo

Nagaoka, A., Takehara, H., Hayashi‐Takagi, A., Noguchi, J., Ishii, K., Shirai, F., Yagishita, S., Akagi, T., Ichiki, T., & Kasai, H. (2016) · Scientific Reports · doi:10.1038/srep26651 · Cited by 60 · see citing works

Methamphetamine‐associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule‐5

Conant, K. E., Lonskaya, I., Szklarczyk, A., Krall, C., Steiner, J. P., Maguire‐Zeiss, K. A., & Seung Taik, L. I. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07153.x · Cited by 58 · see citing works

Matrix metalloproteinase 9 (MMP-9) is indispensable for long term potentiation in the central and basal but not in the lateral nucleus of the amygdala

Górkiewicz, T., Balcerzyk, M., Kaczmarek, L., & Knapska, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00073 · Cited by 58 · see citing works

Inhibition of matrix metalloproteinases prevents the potentiation of nondeprived-eye responses after monocular deprivation in juvenile rats

Spolidoro, M., Putignano, E., Munafò, C., Maffei, L., & Pizzorusso, T. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr158 · Cited by 58 · see citing works

Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system

Jaworski, D. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02035-7 · Cited by 58 · see citing works

Maintenance of long-term potentiation in hippocampal mossy fiber-CA3 pathway requires fine-tuned MMP-9 proteolytic activity

Wiera, G., Wozniak, G., Bajor, M., Kaczmarek, L., & Mozrzymas, J. W. (2013) · Hippocampus · doi:10.1002/hipo.22112 · Cited by 57 · see citing works

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders

Shibasaki, C., Takebayashi, M., Itagaki, K., Abe, H., Kajitani, N., Okada‐Tsuchioka, M., & Yamawaki, S. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw019 · Cited by 56 · see citing works

Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications

Ali, F. T., El-Azeem, E. M. A., Hamed, M. A., Ali, M. A. M., Abdel-Kader, N. M., & Hassan, E. A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.016 · Cited by 55 · see citing works

Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO

Kaliszewska, A., Bijata, M., Kaczmarek, L., & Kossut, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr303 · Cited by 55 · see citing works

Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: Family and case control study

Samochowiec, A., Grzywacz, A., Kaczmarek, L., Bieńkowski, P., Samochowiec, J., Mierzejewski, P., Preuss, U. W., Grochans, E., & Ciechanowicz, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.072 · Cited by 54 · see citing works

MMPs and Soluble ICAM-5 Increase Neuronal Excitability within In Vitro Networks of Hippocampal Neurons

Niedringhaus, M. S., Chen, X., Dzakpasu, R., & Conant, K. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042631 · Cited by 53 · see citing works

Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder

Bobińska, K., Szemraj, J., Czarny, P. L., & Gałecki, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.068 · Cited by 53 · see citing works

Mechanisms of NMDA Receptor- and Voltage-Gated L-Type Calcium Channel-Dependent Hippocampal LTP Critically Rely on Proteolysis That Is Mediated by Distinct Metalloproteinases

Wiera, G., Nowak, D., Hove, I. V., Dzięgiel, P., Moons, L., & Mozrzymas, J. W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2170-16.2016 · Cited by 53 · see citing works

Cleavage of myelin associated glycoprotein by matrix metalloproteinases

Milward, E. A., Kim, K. J., Szklarczyk, A., Nguyen, T. H., Melli, G., Nayak, M. S., Deshpande, D. M., Fitzsimmons, C., Höke, A., Kerr, D. A., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.001 · Cited by 52 · see citing works

Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke

Lenglet, S., Montecucco, F., Mach, F., Schaller, K., Gasche, Y. G., & Copin, J. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0007 · Cited by 52 · see citing works

Plasma Levels of Matrix Metalloproteinase-9 are Independently Associated With Psychosocial Factors in a Middle-Aged Normal Population

Garvin, P., Nilsson, L., Carstensen, J. M., Jonasson, L., & Kristenson, M. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181960e7f · Cited by 51 · see citing works

Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities

Thévenard, J., Verzeaux, L., Devy, J., Etique, N., Jeanne, A., Schneider, C., Hachet, C., Ferracci, G., David, M., Martiny, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103839 · Cited by 51 · see citing works

Matrix Metalloproteinase-9 Gene and Bipolar Mood Disorder

RYBAKOWSKI, J. K., Skibińska, M., Leszczyńska-Rodziewicz, A., Kaczmarek, L., & Hauser, J. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8072-3 · Cited by 49 · see citing works

Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1

Allen, M., Ghosh, S., Ahern, G. P., Villapol, S., Maguire‐Zeiss, K. A., & Conant, K. E. (2016) · Scientific Reports · doi:10.1038/srep35497 · Cited by 49 · see citing works

Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory

Brown, T. E., Wilson‐Poe, A. R., Cocking, D. L., & Sorg, B. A. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.09.003 · Cited by 49 · see citing works

Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter

Škuljec, J., Gudi, V., Ulrich, R., Frichert, K., Yildiz, Ö., Pul, R., Voss, E. V., Wissel, K., Baumgärtner, W., & Stangel, M. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182294fad · Cited by 49 · see citing works

Matrix Metalloproteinase-9 Expression and Protein Levels after Fluid Percussion Injury in Rats: The Effect of Injury Severity and Brain Temperature

Feng, J., Pan, Y., Mao, Q., Liang, Y.-M., & Jiang, J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1067 · Cited by 49 · see citing works

Extracellular proteases in epilepsy

Łukasiuk, K., Wilczynski, G. M., & Kaczmarek, L. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.08.002 · Cited by 48 · see citing works

MMP‐7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function

Szklarczyk, A., Ewaleifoh, O., Béïque, J.-C., Wang, Y., Knorr, D., Haughey, N. J., Malpica-Llanos, T., Mattson, M. P., Huganir, R. L., & Conant, K. E. (2008) · The FASEB Journal · doi:10.1096/fj.07-101402 · Cited by 47 · see citing works

Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study

Devanarayanan, S., Nandeesha, H., Kattimani, S., & Sarkar, S. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0212 · Cited by 47 · see citing works

Ganglioside GM3 Inhibits Matrix Metalloproteinase-9 Activation and Disrupts Its Association with Integrin

Wang, X.-Q., Sun, P., & Paller, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302211200 · Cited by 46 · see citing works

Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex

Li, S., Yu, S., Zhang, C., Shu, H., Liu, S., An, N., Yang, M., Yin, Q., & Yang, H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.009 · Cited by 46 · see citing works

Membrane‐type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases

Langenfurth, A., Rinnenthal, J. L., Vinnakota, K., Prinz, V., Carlo, A.-S., Stadelmann, C., Siffrin, V., Peaschke, S., Endres, M., Heppner, F. L., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23288 · Cited by 45 · see citing works

Plasticity associated with escalated operant ethanol self-administration during acute withdrawal in ethanol-dependent rats requires intact matrix metalloproteinase systems

Smith, A. C. W., Nealey, K. A., Wright, J. W., & Walker, B. M. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.011 · Cited by 45 · see citing works

Activity-Dependent Shedding of the NMDA Receptor Glycine Binding Site by Matrix Metalloproteinase 3: A PUTATIVE Mechanism of Postsynaptic Plasticity

Pauly, T., Ratliff, M., Pietrowski, E., Neugebauer, R., Schlicksupp, A., Kirsch, J., & Kuhse, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002681 · Cited by 45 · see citing works

Neuropsychotoxicity of Abused Drugs: Involvement of Matrix Metalloproteinase-2 and -9 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Methamphetamine-Induced Behavioral Sensitization and Reward in Rodents

Mizoguchi, H., Yamada, K., & Nabeshima, T. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070139 · Cited by 44 · see citing works

Matrix metalloproteinase‐9 is elevated in serum of alcohol abusers

Sillanaukee, P., Kalela, A., Seppä, K., Höyhtyä, M., & Nikkari, S. T. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00975.x · Cited by 44 · see citing works

HuR (Elavl1) and HuB (Elavl2) Stabilize Matrix Metalloproteinase-9 mRNA During Seizure-Induced Mmp-9 Expression in Neurons

Żybura-Broda, K., Wolder-Gontarek, M., Ambrożek-Latecka, M., Choros, A., Bogusz, A., Wilemska, J., & Rylski, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00224 · Cited by 44 · see citing works

Late phase of long‐term potentiation in the mossy fiber—CA3 hippocampal pathway is critically dependent on metalloproteinases activity

Wójtowicz, T., & Mozrzymas, J. W. (2010) · Hippocampus · doi:10.1002/hipo.20787 · Cited by 43 · see citing works

Agrin Expression during Synaptogenesis Induced by Traumatic Brain Injury

Falo, M. C., Reeves, T. M., & Phillips, L. L. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0511 · Cited by 43 · see citing works

Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid

Zhang, J. W., Deb, S., & Gottschall, P. E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01582-2 · Cited by 42 · see citing works

Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D. W., Gill, S. E., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 555 · see citing works

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 192 · see citing works

The extracellular matrix and perineuronal nets in memory

Fawcett, J. W., Fyhn, M., Jendelova, P., Kwok, J. C. F., Ruzicka, J., & Sorg, B. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01634-3 · Cited by 169 · see citing works

Microglia enable mature perineuronal nets disassembly upon anesthetic ketamine exposure or 60-Hz light entrainment in the healthy brain

Venturino, A., Schulz, R., De Jesús-Cortés, H., Maes, M. E., Nagy, B., Reilly-Andújar, F., Colombo, G., Cubero, R. J. A., Schoot Uiterkamp, F. E., Bear, M. F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109313 · Cited by 140 · see citing works

Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder

Seney, M. L., Kim, S.-M., Glausier, J. R., Hildebrand, M. A., Xue, X., Zong, W., Wang, J., Shelton, M. A., Phan, B. N., Srinivasan, C., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.06.007 · Cited by 133 · see citing works

A glial perspective on the extracellular matrix and perineuronal net remodeling in the central nervous system

Tewari, B. P., Chaunsali, L., Prim, C. E., & Sontheimer, H. W. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1022754 · Cited by 107 · see citing works

Upgrading the Physiological Relevance of Human Brain Organoids

Dosso, A. D., Urenda, J., Nguyen, T. N., & Quadrato, G. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.029 · Cited by 101 · see citing works

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo, M., Peeters, C. F. W., Johnson, E. C. B., Vermunt, L., Hok‐A‐Hin, Y. S., van Nee, M. M., Chen‐Plotkin, A. S., Irwin, D. J., Hu, W. T., Lah, J. J., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00300-1 · Cited by 97 · see citing works

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events

Cordaro, M., Cuzzocrea, S., & Crupi, R. (2020) · Antioxidants · doi:10.3390/antiox9030216 · Cited by 98 · see citing works

Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges

Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00352 · Cited by 94 · see citing works

Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases

Wang, M., Xie, Y., & Qin, D. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.005 · Cited by 93 · see citing works

Plasma dilution improves cognition and attenuates neuroinflammation in old mice

Mehdipour, M., Mehdipour, T., Skinner, C. M., Wong, N., Liu, C., Chen, C.-C., Jeon, O. H., Zuo, Y., Conboy, M. J., & Conboy, I. M. (2020) · GeroScience · doi:10.1007/s11357-020-00297-8 · Cited by 83 · see citing works

Molecular signature of extracellular matrix pathology in schizophrenia

Pantazopoulos, H., Katsel, P., Haroutunian, V. H., Chelini, G., Klengel, T., & Berretta, S. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15009 · Cited by 79 · see citing works

Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

García‐González, L., Piłat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 81 · see citing works

Ischemia Reperfusion Injury Induced Blood Brain Barrier Dysfunction and the Involved Molecular Mechanism

Guo, X., Liu, R., Jia, M., Wang, Q., & Wu, J. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03923-x · Cited by 79 · see citing works

The emerging role of furin in neurodegenerative and neuropsychiatric diseases

Zhang, Y., Gao, X., Bai, X., Yao, S., Chang, Y., & Gao, G. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00313-1 · Cited by 79 · see citing works

Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies

Williams, S., Mealer, R. G., Scolnick, E. M., Smoller, J. W., & Cummings, R. D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0761-1 · Cited by 73 · see citing works

Matrix Metalloproteinase-Responsive Drug Delivery Systems

Zhang, C., Jiang, G., & Gao, X. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00266 · Cited by 69 · see citing works

Cell-to-Cell Communication in Learning and Memory: From Neuro- and Glio-Transmission to Information Exchange Mediated by Extracellular Vesicles

Schiera, G., Liegro, C. M. D., & Liegro, I. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010266 · Cited by 67 · see citing works

MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease

Ringland, C., Schweig, J. E., Eisenbaum, M., Paris, D., Ait‐Ghezala, G., MULLAN, M. J., Crawford, F., Abdullah, L. I., & Bachmeier, C. J. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00643-2 · Cited by 64 · see citing works

A Potential Role for Neuroinflammation in ADHD

Vázquez-González, D., Carreón-Trujillo, S., Álvarez‐Arellano, L., Abarca-Merlin, D. M., Domínguez-López, P., Salazar–García, M., & Corona, J. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_15 · Cited by 64 · see citing works

P-Coumaric Acid Reverses Depression-Like Behavior and Memory Deficit Via Inhibiting AGE-RAGE-Mediated Neuroinflammation

Yu, X., Zhang, D., Xiao, C., Zhou, Y., Li, X., Wang, L., He, Z., Reilly, J., Xiao, Z.-Y., & Shu, X. (2022) · Cells · doi:10.3390/cells11101594 · Cited by 59 · see citing works

Incubation of depression: ECM assembly and parvalbumin interneurons after stress

Spijker, S., Koskinen, M.-K., & Riga, D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.015 · Cited by 55 · see citing works

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression

Li, H., Sheng, Z., Khan, S., Zhang, R., Liu, Y., Zhang, Y., Yong, V. W., & Xue, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.861843 · Cited by 54 · see citing works

Circulating Proteins Influencing Psychiatric Disease: A Mendelian Randomization Study

Lu, T., Forgetta, V., Greenwood, C. M. T., Zhou, S., & Richards, J. B. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.015 · Cited by 53 · see citing works

Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

Martino Adami, P. V., Orellana, A., García, P., Kleineidam, L., Alarcón-Martín, E., Montrreal, L., Aguilera, N., Espinosa, A., Abdelnour, C., Rosende-Roca, M., et al. (2022) · Brain · doi:10.1093/brain/awac024 · Cited by 46 · see citing works

Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine

Li, J., Long, Q., Ding, H., Wang, Y., Luo, D., Li, Z., & Zhang, W. (2024) · Advanced Science · doi:10.1002/advs.202308677 · Cited by 47 · see citing works

My Neighbour Hetero — deconstructing the mechanisms underlying heterosynaptic plasticity

Chater, T. E., & Goda, Y. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.10.007 · Cited by 44 · see citing works

Redefining metalloproteases specificity through network proteolysis

Kollet, Ó., Das, A., Karamanos, N. K., Keller, U. A. D., & Sagi, I. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.11.001 · Cited by 40 · see citing works

Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database

Abe, K., Chiba, Y., Hattori, S., Yoshimi, A., Asami, T., Katsuse, O., Suda, A., & Hishimoto, A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116989 · Cited by 41 · see citing works

Perineuronal nets as regulators of parvalbumin interneuron function: Factors implicated in their formation and degradation

Santos‐Silva, T., Colodete, D. A. E., Lisboa, J. R., Freitas, I. D. S., Lopes, C. F. B., Hadera, V., Lima, T. S. A., Souza, A. J., & Gomes, F. V. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13994 · Cited by 36 · see citing works

From molecules to behavior: Implications for perineuronal net remodeling in learning and memory

Sanchez, B., Kraszewski, P., Lee, S., & Cope, E. C. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16036 · Cited by 37 · see citing works

PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model

Pulya, S., Mahale, A. B., Bobde, Y., Routholla, G., Patel, T. K., Swati, S., Biswas, S., Sharma, V., Kulkarni, O. P., & Ghosh, B. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00721 · Cited by 35 · see citing works

Molecular linkage between post-traumatic stress disorder and cognitive impairment: a targeted proteomics study of World Trade Center responders

Kuan, P. F., Clouston, S., Yang, X., Kotov, R., Bromet, E. J., & Luft, B. J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00958-4 · Cited by 33 · see citing works

Upregulation of Matrix Metalloproteinase‐9 Protects against Sepsis‐Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products

Zhang, H., Mao, Y., Zhao, Y., Xu, D., Wang, Y., Xu, C., Dong, W., Zhu, X., Ding, N., Jiang, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8889313 · Cited by 34 · see citing works

Matrix metalloproteinase‑9 in hemorrhagic transformation after acute ischemic stroke (Review)

Guo, P., Li, H., Zhang, X., Liu, Y., Xue, S., Yong, V. W., & Xue, M. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13590 · Cited by 32 · see citing works

The matrix metalloproteinase inhibitor marimastat inhibits seizures in a model of kainic acid-induced status epilepticus

Pijet, B., Konopka, A., Rejmak, E., Stefaniuk, M., Khomiak, D., Bulska, E., Pikul, S., & Kaczmarek, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-78341-y · Cited by 31 · see citing works

Four Pillars of the Montessori Method and Their Support by Current Neuroscience

Catherine, L., Javier, B., & Francisco, G. (2020) · Mind, Brain, and Education · doi:10.1111/mbe.12262 · Cited by 27 · see citing works

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease

Azargoonjahromi, A., & Initiative, A. D. N. (2024) · Molecular Brain · doi:10.1186/s13041-024-01169-4 · Cited by 28 · see citing works

The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study

Seitz‐Holland, J., Seethaler, M., Makris, N., Rushmore, J., Cho, K.-I. K., Rizzoni, E., Vangel, M. G., Şenay, O., Heller, C., Pasternak, O., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00997-5 · Cited by 27 · see citing works

Lysophosphatidic Acid Signalling in Nervous System Development and Function

Birgbauer, E. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08630-2 · Cited by 27 · see citing works

Effects of Mephedrone and Amphetamine Exposure during Adolescence on Spatial Memory in Adulthood: Behavioral and Neurochemical Analysis

Grochecki, P., Smaga, I., Łopatyńska-Mazurek, M., Gibuła‐Tarłowska, E., Kędzierska, E., Listos, J., Talarek, S., Marszałek‐Grabska, M., Hubalewska‐Mazgaj, M., Korga-Plewko, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020589 · Cited by 25 · see citing works

Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors

Liu, N., Wang, X., Wu, H., Lv, X., Xie, H., Guo, Z., Wang, J., Dou, G., Zhang, C., & Sun, M. (2021) · Aging · doi:10.18632/aging.203581 · Cited by 25 · see citing works

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

Kudo, N., Yamamori, H., Ishima, T., Nemoto, K., Yasuda, Y., Fujimoto, M., Azechi, H., Niitsu, T., Numata, S., Ikeda, M., et al. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12098 · Cited by 24 · see citing works

Role of matrix metalloproteinase-9 in neurodevelopmental deficits and experience-dependent plasticity in Xenopus laevis

Gore, S. V., James, E. J., Huang, L.-C., Park, J. J., Berghella, A. P., Thompson, A. C., Cline, H. T., & Aizenman, C. D. (2021) · eLife · doi:10.7554/elife.62147 · Cited by 24 · see citing works

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment

Bade, A. N., McMillan, J., Liu, Y., Edagwa, B., & Gendelman, H. E. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02508-5 · Cited by 28 · see citing works

Role of Neurons and Glia Cells in Wound Healing as a Novel Perspective Considering Platelet as a Conventional Player

Beura, S. K., Panigrahi, A. R., Yadav, P., Agrawal, S., & Singh, S. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02587-4 · Cited by 23 · see citing works

Matrix metalloproteinase‐9: A magic drug target in neuropsychiatry?

Kaczmarek, K., Protokowicz, K., & Kaczmarek, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15976 · Cited by 23 · see citing works

GPR120 Signaling Controls Amyloid-β Degrading Activity of Matrix Metalloproteinases

Kikuchi, K., Tatebe, T., Sudo, Y., Yokoyama, M., Kidana, K., Chiu, Y. W., Takatori, S., Arita, M., Hori, Y., & Tomita, T. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2595-20.2021 · Cited by 22 · see citing works

Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer’s disease patients

Koca, S., Kiris, İ., Şahin, Ş., Çınar, N., Karşıdağ, S., Hanağası, H. A., Yıldız, G. B., & Baykal, A. T. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136799 · Cited by 23 · see citing works

Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort

McGregor, N. W., Thompson, N., O’Connell, K. S., Emsley, R. A., van der Merwe, L., & Warnich, L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.01.044 · Cited by 22 · see citing works

Genetics, molecular control and clinical relevance of habituation learning

Blok, L. E. R., Boon, M., van Reijmersdal, B., Höffler, K. D., Fencková, M., & Schenck, A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104883 · Cited by 21 · see citing works

HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment

Foster, E. G., Gendelman, H. E., & Bade, A. N. (2022) · Pharmaceuticals · doi:10.3390/ph15121533 · Cited by 20 · see citing works

Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain

Łukomska, A., Baranowska‐Bosiacka, I., Dec, K., Pilutin, A., Tarnowski, M., Jakubczyk, K., Żwierełło, W., Skórka-Majewicz, M., Chlubek, D., & Gutowska, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010391 · Cited by 19 · see citing works

Inhibition of MMP-2 and MMP-9 attenuates surgery-induced cognitive impairment in aged mice

Ji, Y., Huang, W., Chen, Y., Zhang, X., Wu, F., Tang, W., Lu, Z., & Huang, C. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110810 · Cited by 19 · see citing works

Weighted Gene Coexpression Network Analysis Identifies Specific Modules and Hub Genes Related to Major Depression

Zhang, G., Xu, S., Yuan, Z., & Shen, L. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s244452 · Cited by 20 · see citing works

BDNF-driven synaptic plasticity requires autocrine matrix metalloproteinase–9 activity

Legutko, D., Bijoch, Ł., Olszak, G., Kuźniewska, B., Kalita, K. B., Yasuda, R., Kaczmarek, L., & Michaluk, P. (2025) · Science Advances · doi:10.1126/sciadv.adx2369 · Cited by 20 · see citing works

HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure

Marks, W. D., Paris, J. J., Barbour, A. J., Moon, J., Carpenter, V. J., McLane, V. D., Lark, A. R. S., Nass, S. R., Zhang, J., Yarotskyy, V., et al. (2021) · eNeuro · doi:10.1523/eneuro.0547-20.2021 · Cited by 18 · see citing works

Quantitative proteomics of cerebrospinal fluid using tandem mass tags in dogs with recurrent epileptic seizures

Baka, R. D., Eckersall, P. D., Horvatić, A., Gelemanović, A., Mrljak, V., McLaughlin, M., Athanasiou, L. V., Papaioannou, N. G., Stylianaki, I., Hanh, H. Q., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103997 · Cited by 18 · see citing works

Identification of the matrix metalloproteinase (MMP) gene family in Japanese flounder (Paralichthys olivaceus): Involved in immune response regulation to temperature stress and Edwardsiella tarda infection

Xie, H., Hu, J., Wang, Y., & Wang, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108878 · Cited by 17 · see citing works

Caveolin-1–Mediated Blood-Brain Barrier Disruption via MMP2/9 Contributes to Postoperative Cognitive Dysfunction

Li, X., Ding, W., Zhang, X., Tang, X., Zheng, Y., Ma, Y., Bao, X., Kang, X., & Zhu, S. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04458-z · Cited by 16 · see citing works

Expression of immune-related proteins and their association with neuropeptides in adolescent patients with anorexia nervosa

Tyszkiewicz‐Nwafor, M., Jowik, K., Paszyńska, E., Dutkiewicz, A., Słopień, A., & Dmitrzak‐Węglarz, M. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102214 · Cited by 16 · see citing works

Shared Inflammatory Pathology of Stroke and COVID-19

Sánchez, K. E., & Rosenberg, G. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095150 · Cited by 16 · see citing works

Genome-Wide Association Study of the Relationship Between Matrix Metalloproteinases and Intracranial Aneurysms

Kim, B. J., Hong, E. P., Youn, D. H., & Jeon, J. P. (2022) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.18.2.163 · Cited by 14 · see citing works

Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis

Tian, Y., Tao, K., Li, S., Chen, X., Wang, R., Zhang, M., & Zhai, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s439779 · Cited by 15 · see citing works

Nuclear factor kappa B signaling within the rat nucleus accumbens core sex-dependently regulates cue-induced cocaine seeking and matrix metalloproteinase-9 expression

Namba, M. D., Phillips, M. N., Neisewander, J. L., & Olive, M. F. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.002 · Cited by 15 · see citing works

Metalloproteinases in nervous system function and pathology: introduction

Rivera, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03172-8 · Cited by 15 · see citing works

Long COVID elevated MMP-9 and release from microglia by SARS-CoV-2 Spike protein

Kempuraj, D., Tsilioni, I., Aenlle, K. K., Klimas, N. G., & Theoharides, T. C. (2024) · Translational Neuroscience · doi:10.1515/tnsci-2022-0352 · Cited by 14 · see citing works

Dynamic regulation of the extracellular matrix in reward memory processes: a question of time

Valeri, J., Gisabella, B., & Pantazopoulos, H. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1208974 · Cited by 13 · see citing works

Effects of uridine administration on hippocampal matrix metalloproteinases and their endogenous inhibitors in REM sleep-deprived rats

Çakır, A., Öcalan, B., Aydin, B., Koç, C., Cansev, M., Süyen, G. G., & Kahveci, N. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148039 · Cited by 13 · see citing works

System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis

Bhuiyan, P., Sun, Z., Khan, M. A., Hossain, M. A., Rahman, M. H., & Qian, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25191 · Cited by 14 · see citing works

Yigansan ameliorates maternal immune activation-induced autism-like behaviours by regulating the IL-17A/TRAF6/MMP9 pathway: Network analysis and experimental validation

Fan, L., Zeng, X., Jiang, Y., Zheng, D., Wang, H., Qin, Q., Li, M., Wang, H., Liu, H., Liang, S., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155386 · Cited by 13 · see citing works

Salidroside protects against ventilation-induced lung injury by inhibiting the expression of matrix metalloproteinase-9

Zhang, H., Dong, W., Li, S., Zhang, Y., Zhou, L., Yang, L., Jiang, L., Wu, T., & Wang, Y. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1967409 · Cited by 12 · see citing works

Extracellular Matrix Recycling as a Novel Plasticity Mechanism With a Potential Role in Disease

Dankovich, T. M., & Rizzoli, S. O. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.854897 · Cited by 12 · see citing works

Gene Therapy for Neuropsychiatric Disorders: Potential Targets and Tools

Lotfi, M., Tambuwala, M. M., Shahcheraghi, S. H., Ayatollahi, J., Aljabali, A. A. A., Zoubi, M. S. A., Panda, P. K., Mishra, V. K., Satija, S., Charbe, N. B., et al. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220304153719 · Cited by 13 · see citing works

Potential Biomarkers of impulsivity in mild traumatic brain injury: A pilot study

Cardoso, M. G. D. F., de Barros, J. L. V. M., de Queiroz, R. A. B., Rocha, N. P., Silver, C., da Silva, A. S., da Silva, E. W. M., Roque, I. G., Carvalho, J. D. L., dos Santos, L. F., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114457 · Cited by 11 · see citing works

Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis

Seitz‐Holland, J., Alemán‐Gómez, Y., Cho, K. I. K., Pasternak, O., Cleusix, M., Jenni, R., Baumann, P., Klauser, P., Conus, P., Hagmann, P., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01814-5 · Cited by 12 · see citing works

Input specificity of NMDA-dependent GABAergic plasticity in the hippocampus

Wiera, G., Jabłońska, J., Lech, A. M., & Mozrzymas, J. W. (2024) · Scientific Reports · doi:10.1038/s41598-024-70278-w · Cited by 11 · see citing works

Targeted therapy of cognitive deficits in fragile X syndrome

Puścian, A., Winiarski, M. J., Borowska, J., Łęski, S., Górkiewicz, T., Chaturvedi, M., Nowicka, K., Wołyniak, M., Chmielewska, J. J., Nikolaev, T., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01527-5 · Cited by 11 · see citing works

The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteinases (MMPs) as promising targets for treatment and rational drug design

Filho, A. J. M. C., Mottin, M., Lós, D. B., Andrade, C. H., & Macêdo, D. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.07.015 · Cited by 11 · see citing works

Autoinducer-2 promotes Pseudomonas aeruginosa PAO1 acute lung infection via the IL-17A pathway

Li, H., Li, X., Ai, Q., & Tan, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.948646 · Cited by 11 · see citing works

Evidence of microglial involvement in the childhood abuse-associated increase in perineuronal nets in the ventromedial prefrontal cortex

Belliveau, C., Rahimian, R., Fakhfouri, G., Hosdey, C., Simard, S., Davoli, M. A., Mirault, D., Bruno Giros, A., Turecki, G., & Mechawar, N. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.013 · Cited by 11 · see citing works

Type 3 adenylyl cyclase in the MOE is involved in learning and memory in mice

Liu, X., Zhou, Y., Yang, D. J., Li, S., Liu, X., & Wang, Z. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112533 · Cited by 11 · see citing works

Evaluation of Anti‐Alzheimer Activity of Synthetic Coumarins by Combination of in Vitro and in Silico Approaches

Orhan, İ. E., Şenol, F. S., Salmas, R. E., Irmak, S., Özgün, Ö., Turgut, G. Ç., Şen, A., Zbancioc, A., Luca, S. V., Skiba, A., et al. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200315 · Cited by 11 · see citing works

The blood-brain barrier in bipolar disorders: A systematic review

Alonso, C. W., McElhatton, F., O’Mahony, B., Campbell, M., Pollak, T. A., & Stokes, P. R. A. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.032 · Cited by 10 · see citing works

Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits

Li, X., Wang, X., Yang, Y., Zhou, J., Wu, X., Zhao, J., Zhang, J., Guo, X., Shao, M., Song, M., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00494-w · Cited by 10 · see citing works

Effect of the Matrix Metalloproteinase Inhibitor Doxycycline on Human Trace Fear Memory

Wehrli, J. M., Xia, Y., Offenhammer, B., Kleim, B., Müller, D., & Bach, D. R. (2023) · eNeuro · doi:10.1523/eneuro.0243-22.2023 · Cited by 9 · see citing works

Effects of minocycline on dendrites, dendritic spines, and microglia in immature mouse brains after kainic acid‐induced status epilepticus

Yang, X., Li, T., Liu, J., Sun, H. B., Cheng, L., Song, X., Han, Z., Luo, H., Han, W., Xie, L., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14352 · Cited by 10 · see citing works

Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Xia, Y., Wehrli, J. M., Abivardi, A., Hostiuc, M., Kleim, B., & Bach, D. R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02732-2 · Cited by 10 · see citing works

Bipolar disorder staging and the impact it has on its management: an update

Dell’Osso, B. M., Cremaschi, L., Macellaro, M., Cafaro, R., & Girone, N. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2355264 · Cited by 9 · see citing works

Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia

Tsilioni, I., Kempuraj, D., & Theoharides, T. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020636 · Cited by 9 · see citing works

Matrix metalloproteinases deregulation in amyotrophic lateral sclerosis

Sánchez-Torres, J. L., Yescas, P., Torres‐Romero, J. C., Espinosa, O. R., López‐Cánovas, L., Tecalco-Cruz, Á. C., Ponce-Regalado, M. D., & Álvarez-Sánchez, M. E. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117175 · Cited by 9 · see citing works

Matrix Metalloproteinase-9 Overexpression Regulates Hippocampal Synaptic Plasticity and Decreases Alcohol Consumption and Preference in Mice

Yin, L.-T., Xie, X., Xue, L., Yang, X. R., Jia, J., Zhang, Y., & Zhang, C. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03053-8 · Cited by 9 · see citing works

Prospective cohort study reveals MMP-9, a neuroplasticity regulator, as a prediction marker of cochlear implantation outcome in prelingual deafness treatment

Matusiak, M., Oziębło, D., Ołdak, M., Rejmak, E., Kaczmarek, L., Skarzynski, P. H., & Skarżyńśki, H. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02732-7 · Cited by 9 · see citing works

Matrix metalloproteinase activity during methamphetamine cued relapse

Lewandowski, S. I., Hodebourg, R., Wood, S. K., Carter, J. S., Nelson, K., Kalivas, P. W., & Reichel, C. M. (2023) · Addiction Biology · doi:10.1111/adb.13279 · Cited by 9 · see citing works

Matrix Metalloproteinase-9 Contributes to Epilepsy Development after Ischemic Stroke in Mice

Pijet, B., Kostrzewska-Księżyk, A., Pijet-Kucicka, M., & Kaczmarek, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020896 · Cited by 8 · see citing works

SIRT1, MMP-9 and TIMP-1 levels in children with specific learning disorder

Işık, C. M., Çiçek, A. U., Özbek, D. Ü., & Bakır, S. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.015 · Cited by 8 · see citing works

The regulatory function of lncRNA and constructed network in epilepsy

Kuang, S., Wang, J., Wei, Z., Zhai, F., & Liang, S. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06648-5 · Cited by 8 · see citing works

Environmental conditions of recognition memory testing induce neurovascular changes in the hippocampus in a sex-specific manner in mice

Cadoret, A., Dion‐Albert, L., Amrani, S., Caron, L., Théberge, M., Turmel, A., Lebel, M., & Ménard, C. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114443 · Cited by 8 · see citing works

Matrix metalloproteinase-3 in brain physiology and neurodegeneration

Lech, A. M., Wiera, G., & Mozrzymas, J. W. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/110319 · Cited by 21 · see citing works

Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System

Ganguly, K., Adhikary, K., Acharjee, A., Acharjee, P., Trigun, S. K., Mutlaq, A. S., Ashique, S., Yasmin, S., Alshahrani, A. M., & Ansari, M. Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135967 · Cited by 23 · see citing works

MMP-9 in Control of Synaptic Plasticity: a Subjective Account

Kaczmarek, L. (2016) · Russian Agency for Digital Standardization · doi:10.20388/omp2016.002.0027 · Cited by 9 · see citing works

The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteinases (MMPs) as promising targets for treatment and rational drug design

Filho, A. J. M. C., Mottin, M., Lós, D. B., Andrade, C. H., & Macêdo, D. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.07.015 · Cited by 11 · see citing works

The matrix metalloproteinases and CNS plasticity: An overview

Milward, E. A., Fitzsimmons, C., Szklarczyk, A., & Conant, K. E. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.010 · Cited by 63 · see citing works